|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01526 RICI HEALTH
Nominal 
0.830 +0.025 (+3.106%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 1,138,578 | -0.548% | 2,795,553 | 2,924,457 | 2,992,689 | 2,375,027 |
| Cost of Sales | (741,475) | 0.572% | (1,588,193) | (1,756,698) | (1,743,180) | (1,447,825) |
| Gross Profit | 397,103 | -2.573% | 1,207,360 | 1,167,759 | 1,249,509 | 927,202 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 8,344 | -- | (12,304) | (37,568) | (9,042) | 3,448 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (330) | -- | (93) | 405 | 958 | 419 | |
| Profit / (Loss) before Taxation | 88,279 | -26.090% | 567,339 | 483,921 | 545,632 | 327,190 | |
| Taxation | (23,143) | -41.699% | (184,311) | (129,266) | (143,657) | (84,041) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | 24,038 | |
| Non-controlling Interests | (19,589) | -17.707% | (75,900) | (57,334) | (38,172) | 23,606 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 45,547 | -18.580% | 307,128 | 297,321 | 363,803 | 290,793 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 43,863 | -12.425% | 97,646 | 123,979 | 112,246 | 104,907 |
| Depreciation & Amortisation | 204,006 | -3.514% | 418,974 | 429,303 | 396,838 | 340,803 |
| Directors' Emoluments | -- | -- | 3,503 | 3,611 | 3,654 | 6,105 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 3.000 | -25.000% | 19.000 | 19.000 | 23.000 | 18.000 |
| DPS (cts) | 0.000 | -- | 1.767 | 4.156 | 11.995 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | 9.301% | 21.873% | 52.151% | -- |
| Cash flow per share ($) | -- | -- | 0.452 | 0.497 | 0.520 | 0.444 |
| NBV per share ($) | 1.056 | -- | 1.035 | 0.846 | 0.709 | 0.600 |
| Remarks: | Real time quote last updated: 09/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 45,547 |
| %Change | -18.580% |
| EPS / (LPS) | RMB 0.030 |
| NBV Per Share (¥) | RMB 1.056 |